Related Experiment Video

Updated: Jul 28, 2026

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

177Lu-PSMA Radiopharmaceutical Therapy or Cabazitaxel?

Michael Froehner, Klaus Zöphel

    Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
    |April 30, 2025
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
    09:49

    A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

    Published on: April 24, 2020

    Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
    10:33

    Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

    Published on: April 25, 2025

    Related Experiment Videos

    Last Updated: Jul 28, 2026

    Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
    09:44

    Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

    Published on: January 29, 2019

    A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods
    09:49

    A Whole Body Dosimetry Protocol for Peptide-Receptor Radionuclide Therapy (PRRT): 2D Planar Image and Hybrid 2D+3D SPECT/CT Image Methods

    Published on: April 24, 2020

    Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment
    10:33

    Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

    Published on: April 25, 2025

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Positron Emission Tomography01:29

    Positron Emission Tomography

    Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
    One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...

    Articles linked to this work by shared authors, journal, and citation graph.

    Iodine-avid Adenomyoepithelioma of the Breast: A Rare Incidental Finding.

    Clinical nuclear medicine·2026

    Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.

    German medical science : GMS e-journal·2025

    Online Radiotherapy: The Paradigm Shift to Real-Time Adaptive Radiotherapy.

    Deutsches Arzteblatt international·2024

    Longitudinal and Multimodal Radiomics Models for Head and Neck Cancer Outcome Prediction.

    Cancers·2023

    Postoperative Radiotherapy of Prostate Cancer: Adjuvant versus Early Salvage.

    Biomedicines·2022

    Optimized Whole-Body PET MRI Sequence Workflow in Pediatric Hodgkin Lymphoma Patients.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2022

    2026 SNMMI Highlights Lecture: Cardiovascular Sciences.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Association of Early Same-Day Posttherapy Whole-Body SPECT/CT Using Visual RECIP 1.0 with Overall Survival During [177Lu]Lu-PSMA-617 Therapy for Metastatic Castration-Resistant Prostate Cancer.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Normal-Organ Absorbed Dose and Response Assessment in α-Particle Radiopharmaceutical Therapy.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    CXCR4-Targeted Molecular Imaging in Hematology and Oncology.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Targeted PET Imaging of Pseudomonas aeruginosa Using a [68Ga]Ga-Pyoverdines Cocktail.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Clinical and Biologic Characterization of a 3-Level Centiloid-Based Classification of Amyloid PET.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2026

    Association of serum testosterone concentrations with central adiposity in men who inject heroin in Mombasa County, Kenya.

    The Pan African medical journal·2026

    Sex-Specific Effects of the Atypical Antipsychotic Risperidone on Performance in a Risky Decision-making Task.

    Behavioural brain research·2026

    Preliminary exploration of effects of the JAK inhibitor tofacitinib on pyoderma gangrenosum: In vitro inhibition of NETs and Th17 differentiation.

    Molecular immunology·2026

    SAFETY OF TAMSULOSIN ALONE OR IN COMBINATION WITH 5Α-REDUCTASE INHIBITORS ON LIPID PROFILE, RENAL FUNCTION, AND LIVER PARAMETERS.

    Georgian medical news·2026

    Defining nonfatal opioid overdoses using administrative health data in the United States and Canada: A scoping review.

    Preventive medicine reports·2026

    Opioid antagonist treatment in alcohol use disorder: extinction, reward memory, and the possible importance of timing.

    Frontiers in neuroscience·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us